130 related articles for article (PubMed ID: 36935339)
1. Liver-stage Plasmodium infection tunes clinical outcomes.
Kaushansky A; Minkah N
Trends Parasitol; 2023 May; 39(5):321-322. PubMed ID: 36935339
[TBL] [Abstract][Full Text] [Related]
2. The Liver-Stage
Sato Y; Ries S; Stenzel W; Fillatreau S; Matuschewski K
Front Immunol; 2019; 10():2554. PubMed ID: 31736970
[TBL] [Abstract][Full Text] [Related]
3. Interplay between liver and blood stages of Plasmodium infection dictates malaria severity via γδ T cells and IL-17-promoted stress erythropoiesis.
Chora ÂF; Marques S; Gonçalves JL; Lima P; Gomes da Costa D; Fernandez-Ruiz D; Marreiros MI; Ruivo P; Carvalho T; Ribeiro RM; Serre K; Heath WR; Silva-Santos B; Tate AT; Mota MM
Immunity; 2023 Mar; 56(3):592-605.e8. PubMed ID: 36804959
[TBL] [Abstract][Full Text] [Related]
4. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
[TBL] [Abstract][Full Text] [Related]
5. γδ-T cells promote IFN-γ-dependent
Ribot JC; Neres R; Zuzarte-Luís V; Gomes AQ; Mancio-Silva L; Mensurado S; Pinto-Neves D; Santos MM; Carvalho T; Landry JJM; Rolo EA; Malik A; Silva DV; Mota MM; Silva-Santos B; Pamplona A
Proc Natl Acad Sci U S A; 2019 May; 116(20):9979-9988. PubMed ID: 31028144
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
7. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
8. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei.
Wang ML; Feng YH; Pang W; Qi ZM; Zhang Y; Guo YJ; Luo EJ; Cao YM
Malar J; 2014 Mar; 13():116. PubMed ID: 24670210
[TBL] [Abstract][Full Text] [Related]
9. G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of
Yi H; Jiang W; Yang F; Li F; Li Y; Zhu W; Li Q; Fakhar SH; Cao Y; Luo L; Zhang W; He Y
Front Immunol; 2021; 12():719189. PubMed ID: 34456927
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
11. Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.
Gerald NJ; Majam V; Mahajan B; Kozakai Y; Kumar S
PLoS One; 2011; 6(9):e24398. PubMed ID: 21935405
[TBL] [Abstract][Full Text] [Related]
12. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
[TBL] [Abstract][Full Text] [Related]
13. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
14. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
Niikura M; Kamiya S; Nakane A; Kita K; Kobayashi F
Int J Parasitol; 2010 Jan; 40(1):101-8. PubMed ID: 19735663
[TBL] [Abstract][Full Text] [Related]
15. γδ T cells in malaria: a double-edged sword.
Pamplona A; Silva-Santos B
FEBS J; 2021 Feb; 288(4):1118-1129. PubMed ID: 32710527
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
17. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
18. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
Tamura T; Kimura K; Yuda M; Yui K
Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
[TBL] [Abstract][Full Text] [Related]
19. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
20. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
